| scholarly article | Q13442814 |
| P50 | author | Beth Karlan | Q95982319 |
| P2093 | author name string | H Phillip Koeffler | |
| Karen M Lyons | |||
| Dong Yin | |||
| Daning Lu | |||
| James O'Kelly | |||
| Jay Vadgama | |||
| Amanda Leiter | |||
| Wenwen Chien | |||
| Julia Sohn | |||
| P2860 | cites work | The C-terminal domain of the regulatory protein NOVH is sufficient to promote interaction with fibulin 1C: a clue for a role of NOVH in cell-adhesion signaling | Q22008746 |
| Proposal for a unified CCN nomenclature | Q24535512 | ||
| Connective tissue growth factor (CCN2) induces adhesion of rat activated hepatic stellate cells by binding of its C-terminal domain to integrin alpha(v)beta(3) and heparan sulfate proteoglycan | Q28235118 | ||
| In Ewing's sarcoma CCN3(NOV) inhibits proliferation while promoting migration and invasion of the same cell type | Q28244685 | ||
| Antiproliferative activity of CCN3: involvement of the C-terminal module and post-translational regulation | Q28291719 | ||
| The angiogenic factor cysteine-rich 61 (CYR61, CCN1) supports vascular smooth muscle cell adhesion and stimulates chemotaxis through integrin alpha(6)beta(1) and cell surface heparan sulfate proteoglycans | Q28578872 | ||
| A multigenic program mediating breast cancer metastasis to bone | Q29614308 | ||
| TGF-beta signaling in tumor suppression and cancer progression | Q29615427 | ||
| Cancer metastasis: building a framework | Q29616783 | ||
| Proviral Rearrangements and Overexpression of a New Cellular Gene (nov) in Myeloblastosis-Associated Virus Type 1-Induced Nephroblastomas | Q31159804 | ||
| Connective tissue growth factor induces apoptosis in human breast cancer cell line MCF-7. | Q33179316 | ||
| A novel variant of WISP1 lacking a Von Willebrand type C module overexpressed in scirrhous gastric carcinoma | Q34092531 | ||
| Elevated levels of connective tissue growth factor, WISP-1, and CYR61 in primary breast cancers associated with more advanced features. | Q34105855 | ||
| Integrin activation controls metastasis in human breast cancer | Q34107054 | ||
| Connective tissue growth factor and its role in lung adenocarcinoma invasion and metastasis | Q34302672 | ||
| Integrin-linked kinase (ILK) and its interactors: a new paradigm for the coupling of extracellular matrix to actin cytoskeleton and signaling complexes | Q34429805 | ||
| Functional domains of CCN1 (Cyr61) regulate breast cancer progression. | Q34788640 | ||
| The angiogenic factor CYR61 in breast cancer: molecular pathology and therapeutic perspectives. | Q35147091 | ||
| CCN proteins: multifunctional signalling regulators | Q35629272 | ||
| Integrins in mammary gland development and differentiation of mammary epithelium | Q35676230 | ||
| Connective-tissue growth factor (CTGF) modulates cell signalling by BMP and TGF-beta | Q36663630 | ||
| Connective tissue growth factor: structure-function relationships of a mosaic, multifunctional protein | Q37144234 | ||
| CTGF enhances the motility of breast cancer cells via an integrin-alphavbeta3-ERK1/2-dependent S100A4-upregulated pathway | Q38301101 | ||
| A novel transforming growth factor beta response element controls the expression of the connective tissue growth factor gene | Q38359426 | ||
| Connective tissue growth factor confers drug resistance in breast cancer through concomitant up-regulation of Bcl-xL and cIAP1. | Q39863143 | ||
| CTGF enhances migration and MMP-13 up-regulation via alphavbeta3 integrin, FAK, ERK, and NF-kappaB-dependent pathway in human chondrosarcoma cells | Q39870517 | ||
| Alternative splicing of Cyr61 is regulated by hypoxia and significantly changed in breast cancer | Q39879649 | ||
| Pathogenic role of connective tissue growth factor (CTGF/CCN2) in osteolytic metastasis of breast cancer | Q40260972 | ||
| Proteolysis of CCN1 by plasmin: functional implications | Q40355376 | ||
| Individual domains of connective tissue growth factor regulate fibroblast proliferation and myofibroblast differentiation | Q40429853 | ||
| Report on the second international workshop on the CCN family of genes | Q42937665 | ||
| Purification and characterization of novel heparin-binding growth factors in uterine secretory fluids. Identification as heparin-regulated Mr 10,000 forms of connective tissue growth factor | Q48046112 | ||
| Suppression of cell proliferation and signaling transduction by connective tissue growth factor in non-small cell lung cancer cells. | Q51153671 | ||
| Expression of connective tissue growth factor mRNA in the fibrous stroma of mammary tumors | Q73169436 | ||
| A very private TGF-beta receptor embrace | Q80614706 | ||
| Abundant retention and release of connective tissue growth factor (CTGF/CCN2) by platelets | Q81144479 | ||
| TGF-beta and cancer | Q81484456 | ||
| P433 | issue | 6 | |
| P921 | main subject | connective tissue | Q25615 |
| cell migration | Q189092 | ||
| angiogenesis | Q539568 | ||
| P304 | page(s) | 1741-1747 | |
| P577 | publication date | 2011-03-23 | |
| P1433 | published in | International Journal of Oncology | Q6051527 |
| P1476 | title | Expression of connective tissue growth factor (CTGF/CCN2) in breast cancer cells is associated with increased migration and angiogenesis | |
| P478 | volume | 38 |
| Q52593636 | A 3D Microfluidic Model to Recapitulate Cancer Cell Migration and Invasion. |
| Q38950681 | A potential role for CCN2/CTGF in aggressive colorectal cancer |
| Q35544076 | An automated cell-counting algorithm for fluorescently-stained cells in migration assays |
| Q39051606 | An in vivo RNAi screen identifies SALL1 as a tumor suppressor in human breast cancer with a role in CDH1 regulation. |
| Q39035249 | BMP9 inhibits the bone metastasis of breast cancer cells by downregulating CCN2 (connective tissue growth factor, CTGF) expression |
| Q36736295 | Breast tumor and stromal cell responses to TGF-β and hypoxia in matrix deposition |
| Q21134800 | CCN2/connective tissue growth factor is essential for pericyte adhesion and endothelial basement membrane formation during angiogenesis |
| Q36059683 | CTGF drives autophagy, glycolysis and senescence in cancer-associated fibroblasts via HIF1 activation, metabolically promoting tumor growth. |
| Q91825046 | Connective tissue growth factor (CCN2) is a matricellular preproprotein controlled by proteolytic activation |
| Q90515465 | Connective tissue growth factor as an unfavorable prognostic marker promotes the proliferation, migration, and invasion of gliomas |
| Q92645971 | Correlation between overexpression of connective tissue growth factor, tumor progression, and clinical prognosis in endometrial cancer patients |
| Q37321759 | Dual roles of CCN proteins in breast cancer progression |
| Q55644712 | Effects of connective tissue growth factor on prostate cancer bone metastasis and osteoblast differentiation. |
| Q38615651 | Emerging role of CCN family proteins in tumorigenesis and cancer metastasis (Review). |
| Q83150439 | Expression of connective tissue growth factor and interleukin-11 in intratumoral tissue is associated with poor survival after curative resection of hepatocellular carcinoma |
| Q35148021 | Expression of connective tissue growth factor in male breast cancer: clinicopathologic correlations and prognostic value |
| Q47371109 | Glucose impairs tamoxifen responsiveness modulating connective tissue growth factor in breast cancer cells. |
| Q41557019 | Identification of a multi-cancer gene expression biomarker for cancer clinical outcomes using a network-based algorithm |
| Q47664161 | In Vitro Validation of the Hippo Pathway as a Pharmacological Target for Canine Mammary Gland Tumors. |
| Q33275485 | Investigating microenvironmental regulation of human chordoma cell behaviour |
| Q35110806 | Investigating the association between polymorphisms in connective tissue growth factor and susceptibility to colon carcinoma |
| Q91822543 | Liver cancer: WISP3 suppresses hepatocellular carcinoma progression by negative regulation of β-catenin/TCF/LEF signalling |
| Q36907108 | Loss of connective tissue growth factor as an unfavorable prognosis factor activates miR-18b by PI3K/AKT/C-Jun and C-Myc and promotes cell growth in nasopharyngeal carcinoma |
| Q34765980 | Reduced CTGF expression promotes cell growth, migration, and invasion in nasopharyngeal carcinoma |
| Q42371632 | Targeting of CCN2 suppresses tumor progression and improves chemo-sensitivity in urothelial bladder cancer |
| Q50962170 | Vemurafenib and trametinib reduce expression of CTGF and IL-8 in V600EBRAF melanoma cells. |
| Q35138841 | WNT-1 inducible signaling pathway protein-1 enhances growth and tumorigenesis in human breast cancer. |
| Q33579391 | miR-124 suppresses multiple steps of breast cancer metastasis by targeting a cohort of pro-metastatic genes in vitro |
Search more.